By Raul Urrutia, Director, Genomics Sciences and Precision Medicine Center (GSPMC), Medical College of Wisconsin And Warren P. Knowles, Professor of Genomics Sciences and Precision Medicine. Professor of Surgery and Biochemistry, Medical College of Wisconsin
The Genomic Sciences and Precision Medicine Center (GSPMC) at the Medical College of Wisconsin (MCW), originally called the Human and Molecular Genetics Center (HMGC),was founded in the...
By Kurt R. Nielsen, President, Lupin Pharmaceuticals
The convergence of vast stores of purposefully collected electronic data, ever increasing computing power, and sophisticated “AI like” software present us with many of the essential ingredients of game changing innovation in drug development.
By Shannon Werb, CIO, Virtual Radiologic
We are fortunate at vRad because we have manufactured much of the technology we use clinically, operationally and financially. And due to our scale, we also manage a significant IT capability which allows us to service our business cost effectively.
By R. Mark Adams, CIO, Good Start Genetics, Cambridge, MA
Biotechnology and biomedicine companies, by nature, experience explosive growth as scientific innovation feeds and fills their markets wif novel products and services.
By Brad Swarbrick, Owner, Quality by Design Consultancy
In 2011 when the US Food and Drug Administration (US-FDA) published their guidance document on Process Validation (PV), this represented the first real attempt by a regulatory authority to mandate the implementation of the Quality by Design.
By Yulia Kogan, Director of Information Technology, Northwell Health
In oncology, genomic science is used to identify tumor mutations, which helps to guide treatment strategies, leading to higher efficacy.
By Amit Vasanji, Ph.D Chief Technology Officer, Imaging, ERT and Brett A. Hoover, Product Management, Imaging, ERT
Trial sponsors who continue to take a traditional, de-centralized approach to imaging may be placing their trial at unnecessary risk, as well as incurring delays and added expense.
By Steve Betts, CIO, Health Care Service Corporation
The unprecedented level of change and unpredictability that we are experiencing within the healthcare industry shows no signs of slowing down.
By Karl Rosenblum, Head, Global Capacity and Risk Strategy, Alcon
This is an exciting time for the manufacturing industry. It's tempting to think of the future as far off. But, actually it is already here, it's just unevenly distributed.
By Michael Smith, CIO & Head of Global Business Services, Mylan Bertek Pharmaceuticals
Businesses today face many obstacles that are increasingly challenging, complex and immense in scale. IT must redefine its role in business and move beyond simply being a support to organization, or we will not survive.
By James Cai, Head of Data Science, Roche
To fully realize the power of AI, it is important for both pharma and academia to invest in research at the intersection of AI and biomedicine. It is also imperative to systematically generate high quality, properly labeled data.
By Dr. Chris Stout, VP - Research & Data Analytics, ATI Physical Therapy
One of the primary, and arguably most important uses of data in healthcare is to accurately prescribe treatment.
By Dr. Jaqui Hodgkinson, VP-Product Development, Pharma & Life Sciences, Elsevier R&D Solutions
Successful drug discovery and development relies upon access to accurate, trusted and reliable data at every stage of the research process.